Company intelligence / Profile preview

Bay Area Retina Associates

Walnut Creek, CA, United States

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Bay Area Retina Associates is conducting and participating in clinical trials for major retinal diseases including phase 3 studies in geographic atrophy (GA) and dry age-related macular degeneration. The group is actively enrolling in and leading both industry-sponsored and investigator-initiated studies, offering access to advanced therapies with a strong publication record in leading ophthalmic journals[4][7].

Therapeutic areas: Ophthalmology
Modalities: Small moleculeBiologicDeviceSteroidAntibody
Industry: Academic Hospital/University/Research

Partnerships

AnnexonStealth BioTherapeuticsLumithera

Beyond the preview

Go deeper on Bay Area Retina Associates.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bay Area Retina Associates.

Explore the full profile